353 results on '"Schmitt, Clemens"'
Search Results
2. Eocene maar sediments record warming of up to 3.5 °C during a hyperthermal event 47.2 million years ago
3. Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model
4. Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19
5. LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression
6. Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19—experiences of a longitudinal series of 92 patients
7. Effect of firing time and wall thickness on the biaxial flexural strength of 3D-printed zirconia
8. Biaxial flexural strength of 3D-printed 3Y-TZP zirconia using a novel ceramic printer
9. Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment
10. N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness
11. Protein Biomarkers in Blood Reflect the Interrelationships Between Stroke Outcome, Inflammation, Coagulation, Adhesion, Senescence and Cancer
12. COVID-19 and cellular senescence
13. Senescence and cancer — role and therapeutic opportunities
14. Strength and reliability of zirconia fabricated by additive manufacturing technology
15. Biaxial Flexural Strength and Vickers Hardness of 3D-Printed and Milled 5Y Partially Stabilized Zirconia.
16. A cFLIP-flop switch for senolysis
17. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma
18. The genomic and transcriptional landscape of primary central nervous system lymphoma
19. Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors
20. Virus-induced senescence is a driver and therapeutic target in COVID-19
21. Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas
22. ASH highlights 2019: “aggressive B-cell lymphoma”
23. AP-1 imprints a reversible transcriptional programme of senescent cells
24. Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network
25. COVID-19: New disease mechanism is simultaneously a therapeutic target
26. MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I
27. Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
28. Cellular Senescence: Defining a Path Forward
29. QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross‐sectional analysis of the randomized AGMT 02 study.
30. Author Correction: AP-1 imprints a reversible transcriptional programme of senescent cells
31. The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
32. The crustacean cuticle does not record chronological age: New evidence from the gastric mill ossicles
33. UnSASPing Senescence: Unmasking Tumor Suppression?
34. Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence
35. Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma
36. Initiation of acute graft-versus-host disease by angiogenesis
37. H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients
38. Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant‐ineligible patients with newly diagnosed multiple myeloma.
39. Fracture Resistance of 3D-Printed Occlusal Veneers Made from 3Y-TZP Zirconia.
40. Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma
41. The dynamic nature of senescence in cancer
42. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
43. B-cell–specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice
44. Senescence-associated reprogramming promotes cancer stemness
45. Daratumumab as a novel treatment option in refractory ITP
46. Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine—A prospective cohort study by the AGMT
47. Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas
48. Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network
49. Randomized Comparison between Krd and Ktd Induction, Followed By K Maintenance or Control in Transplant Non-Eligible Patients with NDMM: Efficacy and Qol Data (AGMT-MM02 Trial)
50. Cox Proportional Hazards Deep Neural Network Identifies Peripheral Blood Complete Remission (PB-CR) to be at Least Equivalent to Morphologic CR in Predicting Outcomes of Patients Treated with Azacitidine - a Prospective Cohort Study By the AGMT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.